Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020

NCT00165659 is registered in ClinicalTrials.gov with Eisai Limited as lead sponsor.

NCT NCT00165659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00165659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020
Lead sponsor
Eisai Limited
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
Not reported
Enrollment
Not reported
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease